grant

Role of Bcl-2 family proteins in the development and therapy of acute myeloid leukaemia (AML) [ 2014 - 2017 ]

Also known as: Towards improved therapy for acute myeloid leukaemia (AML)

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1058746]

Researchers: Prof Suzanne Cory (Principal investigator) ,  Dr Cassandra Vandenberg

Brief description Impairment of cell death (apoptosis) is a critical step in cancer development and limits responsiveness to therapy. This project will investigate the influence of several key apoptosis regulators on the development and treatment of acute myeloid leukaemia (AML), a devastating disease with poor prognosis, and explore whether new drugs known as BH3 mimetics can improve treatment.

Funding Amount $AUD 681,259.76

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857